Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that function as translational repressors and represent an important element in tissue development as well as disease. MiRNA sequences and their target sites in mRNAs show an extensive degree of conservation across species. A single miRNA is now believed to recognize the 3’untranslated region of mRNAs in a sequence-specific manner to inhibit the protein expression of literally hundreds of targeted mRNAs. The human genome encodes more than 1000 miRNAs which target over 60% of mammalian and human transcripts. It is thus not surprising that expression changes in miRNAs can have a far-reaching impact on cellular functions, including the opioid system. Opioids, psychoactive chemicals that resemble morphine in their pharmacological effects are a class of potent analgesics used for treating various forms of acute and chronic pain. The mu opioid receptor is primarily responsible for opioid analgesia and anti-nociceptive tolerance. There is an ever-growing appreciation of miRNAs as important regulators of biological processes where opioids have an important impact, such as regulation of opioid receptors themselves. For example, a large number of splice variants of the primary transcript involve both 3' and 5' splicing of the mu opioid receptor mRNA, many of which can potentially be targeted by miRNAs. Conversely, miRNAs can be regulated by opioids. Two mu opioid receptor agonists, morphine and fentanyl, display differential mechanisms of signalling linked to specific miRNA expression. Moreover, miRNA – opioid connections impact on neuronal cell development, drug addiction, pain perception, neuroimmune system interaction and cell proliferation and tumorigenesis. These aspects will be the subject of this review.
Keywords: Addiction, fentanyl, microRNAs, morphine, mu opioid receptor, opioids, signal transduction, tolerance.
CNS & Neurological Disorders - Drug Targets
Title:MicroRNAs: Emerging Role in the Endogenous μ Opioid System
Volume: 14 Issue: 2
Author(s): Massmo Barbierato, Morena Zusso, Stephen D. Skaper and Pietro Giusti
Affiliation:
Keywords: Addiction, fentanyl, microRNAs, morphine, mu opioid receptor, opioids, signal transduction, tolerance.
Abstract: MicroRNAs (miRNAs) are small non-coding RNAs that function as translational repressors and represent an important element in tissue development as well as disease. MiRNA sequences and their target sites in mRNAs show an extensive degree of conservation across species. A single miRNA is now believed to recognize the 3’untranslated region of mRNAs in a sequence-specific manner to inhibit the protein expression of literally hundreds of targeted mRNAs. The human genome encodes more than 1000 miRNAs which target over 60% of mammalian and human transcripts. It is thus not surprising that expression changes in miRNAs can have a far-reaching impact on cellular functions, including the opioid system. Opioids, psychoactive chemicals that resemble morphine in their pharmacological effects are a class of potent analgesics used for treating various forms of acute and chronic pain. The mu opioid receptor is primarily responsible for opioid analgesia and anti-nociceptive tolerance. There is an ever-growing appreciation of miRNAs as important regulators of biological processes where opioids have an important impact, such as regulation of opioid receptors themselves. For example, a large number of splice variants of the primary transcript involve both 3' and 5' splicing of the mu opioid receptor mRNA, many of which can potentially be targeted by miRNAs. Conversely, miRNAs can be regulated by opioids. Two mu opioid receptor agonists, morphine and fentanyl, display differential mechanisms of signalling linked to specific miRNA expression. Moreover, miRNA – opioid connections impact on neuronal cell development, drug addiction, pain perception, neuroimmune system interaction and cell proliferation and tumorigenesis. These aspects will be the subject of this review.
Export Options
About this article
Cite this article as:
Barbierato Massmo, Zusso Morena, Skaper D. Stephen and Giusti Pietro, MicroRNAs: Emerging Role in the Endogenous μ Opioid System, CNS & Neurological Disorders - Drug Targets 2015; 14 (2) . https://dx.doi.org/10.2174/1871527314666150116123932
DOI https://dx.doi.org/10.2174/1871527314666150116123932 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Functional Role of miR-34 Family in Human Cancer
Current Drug Targets In vivo Radiosensitization of Human Glioma U87 Cells Induced by Upregulated Expression of DUSP-2 after Treatment with Curcumin
Current Signal Transduction Therapy Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Current Psychopharmacology Graphene Family of Nanomaterials: Reviewing Advanced Applications in Drug delivery and Medicine
Current Drug Delivery Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies Salen Mn Complexes are Superoxide Dismutase/Catalase Mimetics that Protect the Mitochondria
Current Inorganic Chemistry (Discontinued) Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review
Current Pharmaceutical Design miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
Current Cancer Drug Targets 2´,3´-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse Transcriptase and HIV-1 Replication
Current HIV Research Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins
Anti-Cancer Agents in Medicinal Chemistry Fluoride Effects: The Two Faces of Janus
Current Medicinal Chemistry The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer – Its Potential Relevance for Therapeutics and Diagnostics
Current Medicinal Chemistry Research Progress on the Antitumor Effects of Rhein: Literature Review
Anti-Cancer Agents in Medicinal Chemistry Evaluation of Biological Effects and Toxicity of Cetyltrimethylammonium Bromide Stabilized Silver Nanoparticles and Cetyltrimethylammonium Bromide Alone Following Intravenous Injection in Mice
Current Nanomedicine Non-histone Methylation of SET7/9 and its Biological Functions
Recent Patents on Anti-Cancer Drug Discovery Techniques to Investigate Neuronal Mitochondrial Function and its Pharmacological Modulation
Current Drug Targets Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry